| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
57,080,000 |
| Market
Cap: |
172.95(M) |
| Last
Volume: |
97,895 |
Avg
Vol: |
97,624 |
| 52
Week Range: |
$1.32 - $4.2 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 5.4 |
| Insider 6 Months : 6.1 |
| Insider 3/6 Months : 11.5 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Galectin Therapeutics is a clinical stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease, cancer and selected other diseases. Co.'s main galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis and in clinical studies to decrease portal hypertension and prevent its complication: the development of esophageal varices. GR-MD-02 has the potential to treat various diseases due to galectin-3's involvement in multiple main biological pathways such as fibrosis, immune cell function and immunity, cell differentiation, cell growth, and apoptosis (cell death).
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
4,500 |
5,000 |
6,598 |
33,898 |
| Total Buy Value |
$14,360 |
$15,253 |
$18,107 |
$61,191 |
| Total People Bought |
3 |
4 |
4 |
5 |
| Total Buy Transactions |
3 |
4 |
5 |
12 |
| Total Shares Sold |
25,000 |
25,000 |
25,000 |
45,000 |
| Total Sell Value |
$76,500 |
$76,500 |
$76,500 |
$118,240 |
| Total People Sold |
1 |
1 |
1 |
2 |
| Total Sell Transactions |
2 |
2 |
2 |
4 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Martin Rod D |
Director |
– • – |
2013-11-01 |
4 |
OE |
$3.00 |
$600,000 |
I/I |
200,000 |
9,457,422 |
|
- |
|
| Mauldin John F |
Director |
– • – |
2013-11-01 |
4 |
AB |
$10.43 |
$4,985 |
D/D |
478 |
16,847 |
|
- |
|
| Martin Rod D |
Director |
– • – |
2013-10-16 |
4 |
OE |
$3.00 |
$900,000 |
I/I |
300,000 |
9,257,422 |
|
- |
|
| 10x Capital Management, Llc |
10% Owner |
– – • |
2013-10-16 |
4 |
OE |
$3.00 |
$900,000 |
D/D |
300,000 |
9,257,422 |
|
- |
|
| Czirr James C |
Executive Chairman |
• • – |
2013-10-16 |
4 |
OE |
$3.00 |
$900,000 |
I/I |
300,000 |
9,257,422 |
|
- |
|
| 10x Capital Management, Llc |
10% Owner |
– – • |
2013-10-08 |
4 |
S |
$12.36 |
$148,270 |
D/D |
(12,000) |
8,957,422 |
|
- |
|
| Martin Rod D |
Director |
– • – |
2013-10-08 |
4 |
S |
$12.36 |
$148,270 |
I/I |
(12,000) |
8,957,422 |
|
- |
|
| Czirr James C |
Executive Chairman |
• • – |
2013-10-08 |
4 |
S |
$12.36 |
$148,270 |
I/I |
(12,000) |
8,957,422 |
|
- |
|
| 10x Capital Management, Llc |
10% Owner |
– – • |
2013-10-07 |
4 |
S |
$11.79 |
$1,179,160 |
D/D |
(100,000) |
8,969,422 |
|
- |
|
| Martin Rod D |
Director |
– • – |
2013-10-07 |
4 |
S |
$11.79 |
$1,179,160 |
I/I |
(100,000) |
8,969,422 |
|
- |
|
| Czirr James C |
Executive Chairman |
• • – |
2013-10-07 |
4 |
S |
$11.79 |
$1,179,160 |
I/I |
(100,000) |
8,969,422 |
|
- |
|
| Mauldin John F |
Director |
– • – |
2013-10-02 |
4 |
AB |
$9.97 |
$1,246 |
D/D |
125 |
16,369 |
|
- |
|
| Mauldin John F |
Director |
– • – |
2013-10-01 |
4 |
AB |
$9.96 |
$3,746 |
D/D |
376 |
16,244 |
|
- |
|
| Mauldin John F |
Director |
– • – |
2013-09-04 |
4 |
AB |
$7.38 |
$4,988 |
D/D |
676 |
15,868 |
|
- |
|
| Mauldin John F |
Director |
– • – |
2013-08-05 |
4 |
AB |
$5.94 |
$4,988 |
D/D |
840 |
15,192 |
|
- |
|
| Mauldin John F |
Director |
– • – |
2013-07-03 |
4 |
AB |
$4.23 |
$3,709 |
D/D |
876 |
14,352 |
|
- |
|
| Mauldin John F |
Director |
– • – |
2013-07-01 |
4 |
AB |
$4.24 |
$1,273 |
D/D |
300 |
13,476 |
|
- |
|
| Mauldin John F |
Director |
– • – |
2013-06-03 |
4 |
AB |
$4.21 |
$4,954 |
D/D |
1,176 |
13,176 |
|
- |
|
| Freeman Kevin D |
Director |
– • – |
2013-05-28 |
4 |
B |
$4.21 |
$4,212 |
D/D |
1,000 |
6,500 |
2.31 |
- |
|
| Shlevin Harold H. |
Chief Operating Officer |
• – – |
2013-04-29 |
4 |
D |
$4.98 |
$231,998 |
D/D |
(46,586) |
53,414 |
|
- |
|
| Shlevin Harold H. |
Chief Operating Officer |
• – – |
2013-04-29 |
4 |
OE |
$2.32 |
$232,000 |
D/D |
100,000 |
100,000 |
|
- |
|
| Prelack Steven |
Director |
– • – |
2013-03-12 |
4 |
D |
$4.22 |
$2,663 |
D/D |
(631) |
2,936 |
|
- |
|
| Prelack Steven |
Director |
– • – |
2013-03-12 |
4 |
OE |
$2.28 |
$2,661 |
D/D |
1,167 |
3,567 |
|
- |
|
| Rome Jerald K |
Director |
– • – |
2013-03-07 |
4 |
OE |
$2.28 |
$5,700 |
D/D |
2,500 |
22,058 |
|
- |
|
| Traber Peter G |
President and CEO |
• • – |
2012-10-12 |
4 |
B |
$2.11 |
$5,287 |
D/D |
2,500 |
510,000 |
2.81 |
- |
|
517 Records found
|
|
Page 15 of 21 |
|
|
0.22 (6.77%) 
